Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Prakash, Pandalai"'
Publikováno v:
Gynecologic Oncology Reports, Vol 33, Iss , Pp 100610- (2020)
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a key component of treatment in non-gynecologic peritoneal surface malignancies. As many as 10–15% of patients with a gastrointestinal primary malignancy will present with carcinomatosis. Maximal
Externí odkaz:
https://doaj.org/article/335074917af14d2380b51235b62067b2
Autor:
Thomas, Amburn, Daniel, Davenport, Reema, Patel, Jessica, Moss, Prakash, Pandalai, Joseph, Kim, Michael, Cavnar
Publikováno v:
The American Surgeon. :000313482211170
Introduction CA19-9 elevation has been reported to predict recurrence after resection of pancreatic ductal adenocarcinoma (PDAC), although only two-thirds of patients are expressers. Preoperatively, cancer-related symptoms predict outcome; however, i
Autor:
Mei Gao, Charles J. Bailey, Megan M. Harper, Michael J. Cavnar, Prakash Pandalai, Shadi A. Qasem, Joseph Kim
Publikováno v:
Cancer Research. 82:A029-A029
Background: Pancreatic ductal adenocarcinoma (PDAC) is highly drug resistant with no change in therapeutic approach for the last decade. The PDAC tumor microenvironment (TME) is highly desmoplastic and associated with altered treatment response. Our
Autor:
Aman Chauhan, Charles Kunos, Donglin Yan, Aman Khurana, Riham Khouli, Michael J. Cavnar, Prakash Pandalai, Joseph Kim, Lowell Brian Anthony
Publikováno v:
Journal of Clinical Oncology. 40:TPS516-TPS516
TPS516 Background: PRRT using Lutetium Lu 177 Dotatate, has been approved by the FDA for metastatic, progressive gastroenteropancreatic neuroendocrine tumors (GEPNETs). Despite an impressive progression-free survival noted in NETTER-1 study, most pat
Publikováno v:
American Journal of Gastroenterology. 113:S842-S843
Autor:
Udo, Rudloff, Russell C, Langan, John E, Mullinax, Joal D, Beane, Seth M, Steinberg, Tatiana, Beresnev, Carole C, Webb, Melissa, Walker, Mary Ann, Toomey, David, Schrump, Prakash, Pandalai, Alexander, Stojadinovic, Itzhak, Avital
A prospective randomized trial was conducted to compare the impact of systemic chemotherapy versus multi-modality therapy (complete cytoreductive surgery (CRS), hyperthermic intraperitoneal chemotherapy (HIPEC), and systemic chemotherapy) on overall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2737f05faf29a68f149b18248c436c94
https://europepmc.org/articles/PMC6301031/
https://europepmc.org/articles/PMC6301031/
Autor:
Laura, Dominici, Guo-Shiou, Liao, Jane, Brock, James D, Iglehart, Parisa, Lotfi, Jack, Meyer, Prakash, Pandalai, Mehra, Golshan
Publikováno v:
The breast journal. 18(5)